Fuxiang Yu
Overview
Explore the profile of Fuxiang Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Wang X, Yu F, Li Z, Chen D, Qi Y, et al.
Transl Oncol
. 2024 Dec;
52():102232.
PMID: 39647324
Background: Gastric cancer (GC) poses a major global health challenge because of its unfavorable prognosis. Elevated telomerase activity has been linked to the rapid growth and invasiveness of GC tumors....
2.
Wu Y, Yu B, Li Y, Yu F, Li Z, Chen D, et al.
Int J Gen Med
. 2022 Feb;
15:1677-1687.
PMID: 35210837
Purpose: Colon cancer is the most commonly diagnosed gastrointestinal cancer. This research intended to evaluate the prognostic values of LINC01006 and miR-3199 for colon cancer and their effects on cell...
3.
Tang Y, Ma N, Luo H, Chen S, Yu F
J Biochem
. 2020 Sep;
168(3):315.
PMID: 32905600
No abstract available.
4.
Sheng J, Zhang B, Chen Y, Yu F
Immunopharmacol Immunotoxicol
. 2020 Aug;
42(6):556-563.
PMID: 32811220
Background: Capsaicin is a chili pepper extract with multiple therapeutic properties including anti-liver fibrosis. However, the paucity of its underlying mechanisms limited its widely clinical application. Methods: In the present...
5.
Wu Y, Li Z, Yu F, Chen D, Jiang F, Qu R, et al.
J BUON
. 2020 Jun;
25(2):899-906.
PMID: 32521884
Purpose: The purpose of this study was to compare the long-term outcomes of laparoscopic and open sphincter-preserving total mesorectal excision (TME) for low rectal cancer (LRC) using propensity score matching...
6.
Tang Y, Ma N, Luo H, Chen S, Yu F
J Biochem
. 2020 Feb;
167(5):525-534.
PMID: 32044992
The apoptosis of hepatocytes contributes to the activation of hepatic stellate cells (HSCs), thus promoting the accumulation of extracellular matrix proteins and aggravating liver fibrosis. Silent information regulator 1 (SIRT1)...
7.
Sun Y, Zhu Q, Zhou M, Yang W, Shi H, Shan Y, et al.
Exp Ther Med
. 2019 Jan;
17(1):639-648.
PMID: 30651845
Various microRNAs (miRNA) have been recognized potential novel tumor markers and have a critical role in cancer development and progression. Recently, methylation of miRNA-148a was identified as a crucial biochemical...
8.
Hao T, Chen J, Zhi S, Zhang Q, Chen G, Yu F
Exp Ther Med
. 2017 Dec;
14(6):5956-5964.
PMID: 29285145
Mesenchymal stem cell (MSC) therapy has emerged as a potential novel method of treating liver fibrosis. To date, bone marrow-derived MSCs (BM-MSCs) and adipose tissue-derived MSCs (AD-MSCs) have not been...
9.
Guo P, Wang Y, Dai C, Tao C, Wu F, Xie X, et al.
Oncogene
. 2017 Dec;
37(9):1220-1236.
PMID: 29242604
Ribosomal protein s15a (RPS15A) plays a promotive role in the mRNA/ribosome interactions during early translation. Our previous study has found that inhibiting RPS15A expression can decrease proliferation and induce cell...
10.
Tang Y, Zhang Q, Zhu Y, Chen G, Yu F
Mol Med Rep
. 2017 Mar;
15(4):1647-1653.
PMID: 28260031
Hepatic stellate cell (HSC) activation serves a key role in liver fibrosis, and is associated with chronic liver diseases. Bilirubin, a product of heme degradation, has been demonstrated to have...